Clinical diagnosis of acute mesenteric ischemia is difficult. The aim of this review is to
provide current status on the search for an accurate plasma biomarker for acute mesenteric …

The recommendations listed in this CPG are, whenever possible, evidence based. An
extensive evidence review was conducted through October 2012, and other selected …

Myocardial ischemia is difficult to diagnose effectively with still few well-defined biochemical
markers for identification in advance, or in the absence of myocardial necrosis.“Ischemia …

BACKGROUND: Early diagnosis of acute myocardial infarction (AMI) can ensure quick and
effective treatment but only 20% of adults with emergency admissions for chest pain have an …

Ischemia‐modified albumin (IMA) is assumed “N‐terminal modified” albumin which is
generated immediately following myocardial ischemia. The diagnosis of IMA is based on …

The number of patients affected by cardiovascular (CV) disease, such as heart failure (HF)
and coronary heart disease (CHD), is growing at an alarming pace. Fortunately, the science …

Objective To examine the diagnostic accuracy of novel biomarkers of myocardial injury and
troponin assays for diagnosis of myocardial infarction. Methods 850 patients randomised to …

Background High-sensitivity cardiac troponin assays have been adopted by many clinical
centres worldwide; however, clinicians are uncertain how to interpret the results. We sought …

The diagnostic usefulness of ischemia-modified albumin in acute coronary syndrome (ACS)
has been questioned. The goal of this systematic review and meta-analysis was to see how …

OBJECTIVE Inflammation and oxidative stress play an important role in the pathogenesis of
lower-extremity artery disease (LEAD). We assessed the prognostic values of inflammatory …